Convergence of immunometabolism and lung cancer therapy: redefining the tumor–immune interface

Abstract Surgery, chemotherapy, radiotherapy, and immune checkpoint blockade remain the mainstays of lung cancer treatment. Despite these approaches, lung cancer continues to be the second leading cause of cancer-related deaths worldwide. Recent insights into the metabolic reprogramming of lung tumo...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Hailin Zhu, Rong Li, Xiurong Wen, Weiting Luo, Qinghua Liu
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2026-02-01
Sarja:	European Journal of Medical Research
Aiheet:	Lung cancer Immunometabolism Tumor microenvironment Metabolic reprogramming Metabolic-targeted therapy
Linkit:	https://doi.org/10.1186/s40001-026-04011-w
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!